Analyst firms · Robert W. Baird · BROS

Robert W. Baird BROS price target and rating history

Dutch Bros Inc. (BROS) · Consumer Discretionary

Robert W. Baird rates Dutch Bros Inc. (BROS) Outperform with a $70 price target, as of its latest action on Jan 6, 2025. It has published 4 rating actions on BROS since October 2021, including 1 upgrade and 1 downgrade. Across 11 firms with a BROS price target in the last 12 months, the median target is $73.

Current rating
Outperform
Price target
$70
Median target, all firms
$73
Actions on BROS
4

Robert W. Baird price target on BROS

$70$63$5620222023202420252026
Robert W. Baird price target on BROS, each point a stated target, October 2021 to January 2025.

Every Robert W. Baird rating on BROS

How other firms rate BROS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
StifelBuy$48Nov 9, 2026
RBC Capital MarketsSector Perform$46Oct 22, 2026
DA DavidsonBuy$60Sep 28, 2026
Seaport Research PartnersBuy$50Sep 16, 2026
Telsey Advisory GroupOutperform$74Jul 31, 2026
StephensOverweight$80Jul 17, 2026
OppenheimerOutperform$72May 1, 2026
BNP Paribas ExaneOutperform$73Mar 30, 2026
Wolfe ResearchOutperform$77Mar 9, 2026
Goldman SachsBuy$75Mar 2, 2026
CitigroupBuy$82Jan 26, 2026

Questions about Robert W. Baird and BROS

What is Robert W. Baird's price target for BROS?
Robert W. Baird's latest stated price target for Dutch Bros Inc. (BROS) is $70, from its action on Jan 6, 2025.
What is Robert W. Baird's rating on BROS?
Robert W. Baird rates BROS Outperform, a bullish rating, as of Jan 6, 2025.
When did Robert W. Baird last change its view on BROS?
On Jan 6, 2025, Robert W. Baird upgrades to Outperform from Neutral, price target $60 to $70.
How does Robert W. Baird's BROS target compare with other analysts?
Across 11 firms with a BROS price target in the last 12 months, the median target is $73.

More BROS rating histories

All Robert W. Baird ratingsBROS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.